Literature DB >> 24838343

A novel VCP mutation underlies scapuloperoneal muscular dystrophy and dropped head syndrome featuring lobulated fibers.

Teerin Liewluck1, Margherita Milone, Michelle L Mauermann, Melissa Castro-Couch, Jane H Cerhan, Naveen S Murthy.   

Abstract

INTRODUCTION: Valosin-containing protein (VCP) is a ubiquitously expressed, multifunctional AAA-ATPase protein. Its dominant mutations cause hereditary inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia (IBMPFD) or amyotrophic lateral sclerosis. The pattern of muscle weakness in IBMPFD patients is variable and includes limb-girdle, scapuloperoneal, distal, or axial distributions. CASE REPORT: We report a 63-year-old man with progressive scapuloperoneal weakness, head drop, and hyperCKemia since age 40 years. Electromyography showed myopathic changes and rare myotonic discharges. Muscle biopsy revealed numerous lobulated fibers, few fibers with glycogen accumulation, and rare fibers with polyglucosan bodies. Rimmed vacuoles and congophilic inclusions, often seen in IBMPFD, were absent. VCP sequencing identified a novel heterozygous c. 1160G>A mutation resulting in p.Asn387Ser substitution.
CONCLUSIONS: Our patient broadens the pathological spectrum of VCP-myopathy and emphasizes the importance of VCP analysis in patients with scapuloperoneal muscular dystrophy despite the absence of Paget disease, dementia, rimmed vacuoles, or intracellular amyloid deposition.
Copyright © 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  VCP; dropped head syndrome; glycogen; lobulated fiber; polyglucosan body; scapuloperoneal muscular dystrophy; valosin-containing protein

Mesh:

Substances:

Year:  2014        PMID: 24838343     DOI: 10.1002/mus.24290

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  12 in total

Review 1.  Multisystem Proteinopathy Due to VCP Mutations: A Review of Clinical Heterogeneity and Genetic Diagnosis.

Authors:  Gerald Pfeffer; Grace Lee; Carly S Pontifex; Roberto D Fanganiello; Allison Peck; Conrad C Weihl; Virginia Kimonis
Journal:  Genes (Basel)       Date:  2022-05-27       Impact factor: 4.141

2.  215th ENMC International Workshop VCP-related multi-system proteinopathy (IBMPFD) 13-15 November 2015, Heemskerk, The Netherlands.

Authors:  Teresinha Evangelista; Conrad C Weihl; Virginia Kimonis; Hanns Lochmüller
Journal:  Neuromuscul Disord       Date:  2016-05-30       Impact factor: 4.296

3.  VCP-dependent muscle degeneration is linked to defects in a dynamic tubular lysosomal network in vivo.

Authors:  Alyssa E Johnson; Huidy Shu; Anna G Hauswirth; Amy Tong; Graeme W Davis
Journal:  Elife       Date:  2015-07-13       Impact factor: 8.140

Review 4.  Mutations in the Human AAA+ Chaperone p97 and Related Diseases.

Authors:  Wai Kwan Tang; Di Xia
Journal:  Front Mol Biosci       Date:  2016-12-01

5.  An engineered, quantifiable in vitro model for analysing the effect of proteostasis-targeting drugs on tissue physical properties.

Authors:  Sandra Loaiza; Silvia A Ferreira; Tamara M Chinn; Alex Kirby; Elena Tsolaki; Camilla Dondi; Katarzyna Parzych; Adam P Strange; Laurent Bozec; Sergio Bertazzo; Martin A B Hedegaard; Eileen Gentleman; Holger W Auner
Journal:  Biomaterials       Date:  2018-08-21       Impact factor: 12.479

6.  Dropped head syndrome due to neuromuscular disorders: Clinical manifestation and evaluation.

Authors:  Ahmet Z Burakgazi; Perry K Richardson; Mohammad Abu-Rub
Journal:  Neurol Int       Date:  2019-06-19

7.  Resolving a Multi-Generational Neuromuscular Mystery in a Family Presenting with a Variable Scapuloperoneal Syndrome in a c.464G>A, p.Arg155His VCP Mutation.

Authors:  Nivedita U Jerath
Journal:  Case Rep Genet       Date:  2019-10-09

8.  Panorama of the distal myopathies.

Authors:  Marco Savarese; Jaakko Sarparanta; Anna Vihola; Per Harald Jonson; Mridul Johari; Salla Rusanen; Peter Hackman; Bjarne Udd
Journal:  Acta Myol       Date:  2020-12-01

9.  Immunoreactivity of valosin-containing protein in sporadic amyotrophic lateral sclerosis and in a case of its novel mutant.

Authors:  Takashi Ayaki; Hidefumi Ito; Hiroko Fukushima; Takeshi Inoue; Takayuki Kondo; Akito Ikemoto; Takeshi Asano; Akemi Shodai; Takuji Fujita; Satoshi Fukui; Hiroyuki Morino; Satoshi Nakano; Hirofumi Kusaka; Hirofumi Yamashita; Masafumi Ihara; Riki Matsumoto; Jun Kawamata; Makoto Urushitani; Hideshi Kawakami; Ryosuke Takahashi
Journal:  Acta Neuropathol Commun       Date:  2014-12-10       Impact factor: 7.801

10.  SVIP is a molecular determinant of lysosomal dynamic stability, neurodegeneration and lifespan.

Authors:  Alyssa E Johnson; Brian O Orr; Richard D Fetter; Armen J Moughamian; Logan A Primeaux; Ethan G Geier; Jennifer S Yokoyama; Bruce L Miller; Graeme W Davis
Journal:  Nat Commun       Date:  2021-01-21       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.